Biomea Fusion, Inc. (BMEA)
$1.42+3.65%Close
SELLCRISIS · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $103M
- Beta
- -0.30
- P/E (TTM)
- -2.52
- Short % float
- 20.88%
- Days to cover
- 5.7
- SI change
- +6.5%
- 1W
- +11.81%
- 1M
- -16.47%
- vs SPY 1W
- +10.65%
- vs SPY 1M
- -19.46%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BMEA?
- LOPJLB’s latest quantitative signal on Biomea Fusion, Inc. (BMEA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BMEA in?
- Biomea Fusion, Inc. (BMEA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Biomea Fusion, Inc. (BMEA) do?
- Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. Itâs lead clinical programâs drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical trials of icovamenib for the treatment of Type 1 and Type 2 diabetes; COVALENT-211, which is in P…